SARS-CoV-2 / COVID-19

Luka Cicin-Sain, head of the department "Viral Immunology" at the HZI, explains in an interview with Helmholtz which virus variants we can expect in the future and how the pandemic could develop after Omikron. [read more]

There are more coronavirus cases than ever in Germany, even though more than two-thirds of people are fully vaccinated. In an Interview with DW, epidemiologist Gérard Krause points out why the vaccination still is very effective. [read more]

The delta variant of SARS-CoV-2 is spreading rapidly, even in countries with a high vaccination rate. In this article by Deutsche Welle, experts including HZI researcher Peggy Riese explain why vaccines cannot be held responsible for the emergence of new variants. [read more]

The pace of Covid-19 vaccinations in Europe is slowing down. In an article by CNN, epidemiologist Berit Lange comments on the situation in Germany and discusses incentives to boost vaccination rates. [read more]

Little is yet known about the corona immunity duration. "At least we are now gaining initial insights into what it looks like after periods of about six months," Guzmán explains in a recent article published by the Helmholtz Association. [read more]

SORMAS software was originally developed for managing the Ebola epidemic in Nigeria. The Nigerian newspaper The Guardian reports how this gave the country a unique advantage when the pandemic hit. [read more]

Autumn and winter are commonly the season for colds and influenza. In an interview with DW, Gérard Krause assessed what happens when these infections meet COVID-19. [read more]

Immunologist Michael Meyer-Hermann explains in an interview with the International Journalists' Network (IJN) how Germany is acting against COVID-19 and what can be expected in the next months. [read more]